Celtax 30mg/5ml (Paclitaxel Vials) 30mg/5ml

Celtax 30mg/5ml is a prescription chemotherapy medication used for cancer treatment. This vial formulation contains paclitaxel, a taxane derivative, for intravenous administration. Ideal for oncology protocols, it’s manufactured by Celon Laboratories in India. Store at room temperature for stability.

Strength

30mg/5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Celon Laboratories PVT.LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Celtax 30mg/5ml is primarily used to treat various cancers, including ovarian, breast, and lung cancers. It may also be prescribed for Kaposi’s sarcoma in patients with AIDS. Healthcare providers determine suitability based on individual medical conditions. This medication works by stabilizing microtubules to inhibit cancer cell division.

Side Effects

Patients may experience temporary hair thinning or fatigue during treatment with Celtax 30mg/5ml. Mild nausea or joint pain can occur but typically resolves after therapy. Some individuals report numbness or tingling in hands or feet. These effects vary by person and treatment duration.

Precautions & Warnings

Handle Celtax 30mg/5ml with care, as it is a cytotoxic agent. Avoid direct skin contact; use gloves and protective clothing during preparation. Pregnant or breastfeeding individuals should consult a healthcare provider before exposure. Keep vials sealed until ready for use to maintain sterility.

Avoid Interactions

Celtax 30mg/5ml may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Combining it with certain vaccines or live treatments could reduce efficacy. Alcohol and grapefruit products might amplify side effects. Always disclose all medications to your healthcare team.

Frequently Asked Questions

Celtax 30mg/5ml is used to treat specific cancers like ovarian, breast, and lung cancer, as well as Kaposi’s sarcoma in AIDS patients.

This medication is given intravenously by a healthcare professional in a clinical setting.

Celtax 30mg/5ml requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Common effects include hair thinning, fatigue, mild nausea, and joint pain, which vary by individual.

Consult a healthcare provider before using Celtax 30mg/5ml if pregnant or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.